Moreover, the PLAGL2 expression was positively correlated to the depth of tumor penetration in colorectal cancer; Guo et al. 9 found that PLAGL2 expression in prostate cancer was significantly higher than PLAGL2 expression in benign prostatic hyperplasia tissue. Here, PLAGL2 is linked to benign prostatic hyperplasia.